Efficacy and Safety of the MDM2-p53 Antagonist Brigimadlin (BI 907828) in Patients with Advanced Biliary Tract Cancer: A Case Series.
Noboru YamamotoAnthony W TolcherNavid HafezIwona LugowskaRodryg RamlauTeresa MacarullaJunxian GengJian LiMichael TeufelAngela MärtenPatricia LoRussoPublished in: OncoTargets and therapy (2024)
-amplified BTC, and warrants further investigation.